Make Your Dailies Informative

Human Biosciences plans to launch 2 wound care products in India

It added that the corporate “plans to launch two of its wound care management products, ‘Medifil’ and ‘Skin Temp’, in India soon”.

PTI | , New Delhi

UPDATED ON SEP 06, 2021 10:01 PM IST

The US-based Human Biosciences (HBS) on Sunday stated it’s planning to introduce two wound care products in the Indian market quickly.

The two products are named ‘Medifil’ and ‘Skin Temp’, the corporate stated in a press release.

It added that the corporate “plans to launch two of its wound care management products, ‘Medifil’ and ‘Skin Temp’, in India soon”.

These products can be launched with unique advertising and marketing and distribution channels, the assertion stated.

Some of its wound care products are already accessible in India which can be manufactured on the firm’s unit in Ahmedabad, Gujarat, HBS stated.

“Our mission at HBS is to provide customers with healthcare products of high quality at an affordable price.

“We are planning to arrange extra manufacturing items in India to improve manufacturing and broaden our attain, in order that extra folks can avail advantages of those products,” HBS founder Manoj Jain was quoted as saying in the assertion.

Also Read :   Do you know Jeff Bezos, world's richest man, has an unlimited soft-serve ice-cream machine at his Los Angles residence?

‘Medifil’ and ‘Skin Temp’ assist cease bleeding and play energetic function in therapeutic of the wound, he stated.

Close

Follow Us on Facebook and Twitter

Check out information from India, World, Health, Sports, Business, Economy, Politics, Technology, Science, Education, Entertainment, Lifestyle and plenty of extra.

Disclaimer: This article was compiled and modified robotically by a pc programme and was not produced by TheUrbanPress. You might all the time learn the unique content material on the writer’s web site.
Leave A Reply

Your email address will not be published.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More